Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility in Devens, Massachus
PRINCETON, N.J. , June 08 /Businesswire/ - $BMY announces U.S. Food and Drug Administration approval for commercial production of #CARTcelltherapy at their newest facility in Devens, Massachusetts, expanding #manufacturing footprint for long-term supply of the company’s cell therapy portfolio